migraines

Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs
Yahoo/Reuters
Tue, 11/9/21 - 10:38 am
Pfizer
Biohaven
migraines
rimegepant
zavegepant
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Fierce Pharma
Fri, 10/22/21 - 12:42 pm
Biohaven
migraines
Nurtec ODT
Amgen
AbbVie
Biohaven migraine drug sales again top Wall Street forecasts
BioPharma Dive
Wed, 10/6/21 - 11:20 pm
Biohaven
migraines
Nurtec ODT
AbbVie’s Qulipta Set to Become Blockbuster in the Migraine Market
Clinical Trials Arena
Sun, 10/3/21 - 08:11 pm
AbbVie
Qulipta
migraines
FDA
AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug
Endpoints
Wed, 09/29/21 - 11:04 am
AbbVie
Qulipta
migraines
Allergan
Biohaven
FDA
No joy for Ajovy: Teva's migraine drug can't find a win in meta-analysis versus Biohaven, AbbVie meds
Fierce Pharma
Thu, 09/9/21 - 11:11 am
Teva Pharmaceutical
Eli Lilly
Amgen
Ajovy
Biohaven
migraines
Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users
Fierce Pharma
Tue, 08/24/21 - 10:47 am
Biohaven Pharmaceuticals
migraines
celebrity endorsements
Nurtec
digital advertising
DTC advertising
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug
BioSpace
Mon, 08/16/21 - 10:15 pm
Teva Pharmaceutical
patents
migraines
Ajovy
Eli Lilly
Emgality
Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma
BioPharma Dive
Wed, 07/14/21 - 10:34 pm
Biohaven
migraines
drug launches
DTC advertising
Nurtec
Why Glaxo should buy Biohaven
EP Vantage
Fri, 07/9/21 - 09:46 am
Biohaven
GSK
Nurtec
migraines
M&A
Biohaven Leaps After Posting $93M Sales for Migraine Drug
TheStreet.com
Wed, 07/7/21 - 12:00 pm
Biohaven
migraines
Nurtec
Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen
Fierce Pharma
Tue, 06/15/21 - 11:41 pm
Novartis
Amegen
Aimovig
migraines
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study
Fierce Pharma
Tue, 06/15/21 - 10:35 am
Eli Lilly
Emgality
migraines
Biohaven
Nurtec
Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity
BioSpace
Fri, 06/4/21 - 10:37 am
AbbVie
migraines
atogepant
Biohaven earns preventative nod for migraine med Nurtec, snaring a much-needed leg up over AbbVie
Endpoints
Fri, 05/28/21 - 11:16 am
Biohaven
FDA
migraines
Nurtec
AbbVie
AbbVie Receives NDA for Atogepant, Aims to Stop Migraines in Their Tracks
BioSpace
Wed, 03/31/21 - 10:58 pm
AbbVie
atogepant
migraines
FDA
Nerivio: New Drug-Free Wearable Technology Used to Treat Migraines
Xtalks
Fri, 03/5/21 - 10:22 am
Nerivio
migraines
digital therapeutics
FDA
Theranica
wearables
devices
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
Axsome’s Migraine Drug Provides Relief in Phase III Trial
BioSpace
Sun, 01/3/21 - 04:19 pm
Axsome Therapeutics
clinical trials
AXS-07
migraines
Amgen and Novartis tap TV host to jump-start migraine conversations—and fuel understanding
Fierce Pharma
Wed, 12/16/20 - 10:40 pm
Aimovig
Amgen
Novartis
migraines
celebrity endorsements

Pages